{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:24:10Z","timestamp":1787063050011,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2016-CoG 725034"],"award-info":[{"award-number":["ERC-2016-CoG 725034"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2022-POC2 101101088"],"award-info":[{"award-number":["ERC-2022-POC2 101101088"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/50006\/2019"],"award-info":[{"award-number":["UID\/QUI\/50006\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejpb.2024.114276","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T12:29:20Z","timestamp":1712233760000},"page":"114276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Can (Natural) deep eutectic systems increase the efficacy of ocular therapeutics?"],"prefix":"10.1016","volume":"198","author":[{"given":"C\u00e9lia","family":"Sarmento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rita Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114276_b0005","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","article-title":"Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study","volume":"9","author":"Bourne","year":"2021","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.ejpb.2024.114276_b0010","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study","volume":"9","author":"Steinmetz","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ejpb.2024.114276_b0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/09286586.2017.1281426","article-title":"The economic impact of blindness in Europe","volume":"24","author":"Chakravarthy","year":"2017","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.ejpb.2024.114276_b0020","unstructured":"Blindness and vision impairment. WHO https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment (2021)."},{"key":"10.1016\/j.ejpb.2024.114276_b0025","doi-asserted-by":"crossref","unstructured":"Addo, E., Bamiro, O. A. & Siwale, R. Anatomy of the eye and common diseases affecting the eye. in Ocular Drug Delivery: Advances, Challenges and Applications 11\u201325 (Springer International Publishing, 2016). doi:10.1007\/978-3-319-47691-9_2.","DOI":"10.1007\/978-3-319-47691-9_2"},{"key":"10.1016\/j.ejpb.2024.114276_b0030","unstructured":"Boyd, K. & Turbert, D. Eye Anatomy: Parts of the Eye and How We See. American Academy of Ophthalmology https:\/\/www.aao.org\/eye-health\/anatomy\/parts-of-eye (2021)."},{"key":"10.1016\/j.ejpb.2024.114276_b0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbapap.2005.08.023","article-title":"Human tear viscosity: An interactive role for proteins and lipids","volume":"1753","author":"Gouveia","year":"2005","journal-title":"Biochimica Et. Biophysica Acta - Proteins and Proteomics"},{"key":"10.1016\/j.ejpb.2024.114276_b0040","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","article-title":"Recent advances in ocular drug delivery","volume":"39","author":"Achouri","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2024.114276_b0045","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular drug delivery: Present innovations and future challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J. Pharmacol. Experiment. Therapeutics"},{"key":"10.1016\/j.ejpb.2024.114276_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114276_b0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/1874364101812010226","article-title":"Development of in vitro methodologies to investigate binding by sodium hyaluronate in eye drops to corneal surfaces","volume":"12","author":"Bock","year":"2018","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.ejpb.2024.114276_b0060","doi-asserted-by":"crossref","unstructured":"Bourlais, L. et al. Ophthalmic Drug Delivery Systems Recent Advances. 17, 33\u201358 (1998).","DOI":"10.1016\/S1350-9462(97)00002-5"},{"key":"10.1016\/j.ejpb.2024.114276_b0065","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","article-title":"Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases","volume":"354","author":"Onugwu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114276_b0070","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejpb.2015.02.032","article-title":"Undefined role of mucus as a barrier in ocular drug delivery","volume":"96","author":"Ruponen","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114276_b0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.exer.2003.09.019","article-title":"Functional aspects of the tear film lipid layer","volume":"78","author":"Bron","year":"2004","journal-title":"Exp. Eye Res."},{"issue":"Suppl 2","key":"10.1016\/j.ejpb.2024.114276_b0080","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S0039-6257(00)00203-4","article-title":"The ocular surface and tear film and their dysfunction in dry eye disease","volume":"45","author":"Rolando","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114276_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120924","article-title":"Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies","volume":"607","author":"Mofidfar","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114276_b0090","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drudis.2012.10.005","article-title":"Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers","volume":"18","author":"Gan","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2024.114276_b0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2004.07.001","article-title":"Model of transient drug diffusion across cornea","volume":"99","author":"Zhang","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114276_b0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/02713688809031801","article-title":"Comparison of conjunctival and corneal surface areas in rabbit and human","volume":"7","author":"Watsky","year":"1988","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2024.114276_b0105","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/jps.21200","article-title":"Molecular design for enhancement of ocular penetration","volume":"97","author":"Shirasaki","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114276_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5301\/EJO.2010.6049","article-title":"Blood-retinal barrier","volume":"21","author":"Cunha-Vaz","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114276_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13020207","article-title":"Formulation considerations for the management of dry eye disease","volume":"13","author":"Agarwal","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114276_b0120","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/pharmaceutics15041094","article-title":"Overcoming treatment challenges in posterior segment diseases with biodegradable nano-based drug delivery systems","volume":"15","author":"Wu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114276_b0125","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3390\/pharmaceutics15071862","article-title":"Innovative strategies for drug delivery to the ocular posterior segment","volume":"15","author":"Gabai","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114276_b0130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114276_b0135","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/sc500096j","article-title":"Natural deep eutectic solvents \u2013 solvents for the 21st century","volume":"2","author":"Paiva","year":"2014","journal-title":"ACS Sustain. Chem. Eng."},{"key":"10.1016\/j.ejpb.2024.114276_b0140","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ejoc.201501197","article-title":"Deep eutectic solvents: the organic reaction medium of the century","volume":"2016","author":"Alonso","year":"2016","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejpb.2024.114276_b0145","doi-asserted-by":"crossref","unstructured":"Abbott, A. P., Capper, G., Davies, D. L., Rasheed, R. K. & Tambyrajah, V. Novel solvent properties of choline chloride\/urea mixturesElectronic supplementary information (ESI) available: spectroscopic data. See http:\/\/www.rsc.org\/suppdata\/cc\/b2\/b210714g\/. Chemical Communications 70\u201371 (2003) doi:10.1039\/b210714g.","DOI":"10.1039\/b210714g"},{"key":"10.1016\/j.ejpb.2024.114276_b0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.foodchem.2015.03.123","article-title":"Tailoring properties of natural deep eutectic solvents with water to facilitate their applications","volume":"187","author":"Dai","year":"2015","journal-title":"Food Chem."},{"key":"10.1016\/j.ejpb.2024.114276_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2019.111028","article-title":"Deep eutectic solvents: an overview on their interactions with water and biochemical compounds","volume":"288","author":"El Achkar","year":"2019","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2024.114276_b0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.aca.2012.12.019","article-title":"Natural deep eutectic solvents as new potential media for green technology","volume":"766","author":"Dai","year":"2013","journal-title":"Analytica Chimica Acta"},{"key":"10.1016\/j.ejpb.2024.114276_b0165","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1104\/pp.111.178426","article-title":"Are natural deep eutectic solvents the missing link in understanding cellular metabolism and physiology?","volume":"156","author":"Choi","year":"2011","journal-title":"Plant Physiol."},{"key":"10.1016\/j.ejpb.2024.114276_b0170","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1021\/acssuschemeng.7b01707","article-title":"how do animals survive extreme temperature amplitudes? the role of natural deep eutectic solvents","volume":"5","author":"Gertrudes","year":"2017","journal-title":"ACS Sustain. Chem. Eng."},{"key":"10.1016\/j.ejpb.2024.114276_b0175","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.molliq.2016.01.038","article-title":"Properties and thermal behavior of natural deep eutectic solvents","volume":"215","author":"Craveiro","year":"2016","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2024.114276_b0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chemosphere.2013.05.013","article-title":"Chemosphere assessment of cytotoxicity and toxicity for phosphonium-based deep eutectic solvents","volume":"93","author":"Hayyan","year":"2013","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejpb.2024.114276_b0185","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114276_b0190","first-page":"715","volume":"85","author":"Zhu","year":"2008","journal-title":"Effect of Viscosity on Tear Drainage and Ocular Residence Time"},{"key":"10.1016\/j.ejpb.2024.114276_b0195","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/eye.2012.211","article-title":"The effect of pH, dilution, and temperature on the viscosity of ocular lubricants \u2014 shift in rheological parameters and potential clinical significance","volume":"26","author":"Rahman","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.ejpb.2024.114276_b0200","volume":"463\u2013466","author":"Zaki","year":"1986","journal-title":"A Comparison of the Effect of Viscosity on the Precorneal Residence of Solutions in Rabbit and Man"},{"key":"10.1016\/j.ejpb.2024.114276_b0205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00137947","article-title":"The viscosity of human tears","volume":"15","author":"Tiffany","year":"1991","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114276_b0210","unstructured":"Not a dry eye in the house: Eye drop rheology profiling. Centre for Industrial Rheology https:\/\/www.rheologylab.com\/articles\/pharma\/rheology-lubricating-eye-drops\/."},{"key":"10.1016\/j.ejpb.2024.114276_b0215","unstructured":"Kr\u00e4mer, I., Haber, M. & Duis, A. Formulation Requirements for the Ophthalmic Use of Antiseptics."},{"key":"10.1016\/j.ejpb.2024.114276_b0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jop.2012.0200","article-title":"Novel strategies for anterior segment ocular drug delivery","volume":"29","author":"Cholkar","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2024.114276_b0225","unstructured":"Aroso, I. M. et al. Fundamental studies on natural deep eutectic solvents: physico-chemical, thermal and rheological properties. NWBC 2015 - 6th Nordic Wood Biorefinery Conference 155\u2013160 (2015)."},{"key":"10.1016\/j.ejpb.2024.114276_b0230","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.molliq.2017.06.051","article-title":"Natural deep eutectic solvents from choline chloride and betaine \u2013 physicochemical properties","volume":"241","author":"Aroso","year":"2017","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2024.114276_b0235","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1002\/slct.201701223","article-title":"Gas solubility and rheological behavior of natural deep eutectic solvents (NADES) via combined experimental and molecular simulation techniques","volume":"2","author":"Altamash","year":"2017","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejpb.2024.114276_b0240","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.molliq.2018.02.049","article-title":"Gas solubility and rheological behavior study of betaine and alanine based natural deep eutectic solvents (NADES)","volume":"256","author":"Altamash","year":"2018","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2024.114276_b0245","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/pharmaceutics15051553","article-title":"Using natural deep eutectic systems as alternative media for ocular applications","volume":"15","author":"Sarmento","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114276_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/861904","article-title":"Ophthalmic drug dosage forms: characterisation and research methods","volume":"2014","author":"Baranowski","year":"2014","journal-title":"Scientific World J."},{"key":"10.1016\/j.ejpb.2024.114276_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2022.214919","article-title":"Cyclodextrin-based ocular drug delivery systems: a comprehensive review","volume":"476","author":"Wang","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejpb.2024.114276_b0260","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1039\/D0CC00460J","article-title":"Cyclodextrins: from solute to solvent","volume":"56","author":"El Achkar","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejpb.2024.114276_b0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.4.3.12","article-title":"Natural bioadhesive biodegradable nanoparticle-based topical ophthalmic formulations for management of glaucoma","volume":"4","author":"Ibrahim","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ejpb.2024.114276_b0270","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/10717544.2019.1622608","article-title":"New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment","volume":"26","author":"Sun","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114276_b0275","article-title":"Current developments and future perspectives on biotechnology applications of natural deep eutectic systems","volume":"39","author":"Jesus","year":"2023","journal-title":"Curr. Opin. Green Sustainable Chem."},{"key":"10.1016\/j.ejpb.2024.114276_b0280","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1038\/s41598-022-06831-2","article-title":"The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration","volume":"12","author":"Juhong","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2024.114276_b0285","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jiec.2018.05.005","article-title":"Natural deep eutectic solvents as a storage medium for human interferon-\u03b12: a green and improved strategy for room-temperature biologics","volume":"65","author":"Lee","year":"2018","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.ejpb.2024.114276_b0290","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1039\/D2GC03415H","article-title":"Unveiling the potential of deep eutectic solvents to improve the conformational and colloidal stability of immunoglobulin G antibodies","volume":"25","author":"Dhiman","year":"2023","journal-title":"Green Chem."},{"key":"10.1016\/j.ejpb.2024.114276_b0295","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/polym13081340","article-title":"Potential of stimuli-responsive in situ gel system for sustained ocular drug delivery: recent progress and contemporary research","volume":"13","author":"Pandey","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2024.114276_b0300","unstructured":"American Society of Health-System Pharmacists. Timolol Ophthalmic Gel Forming Solution. https:\/\/www.ashp.org\/drug-shortages\/current-shortages\/drug-shortage-detail.aspx?id=708 (2023)."},{"key":"10.1016\/j.ejpb.2024.114276_b0305","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/pharmaceutics13010108","article-title":"Ocular drug delivery to the retina: current innovations and future perspectives","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114276_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.crfs.2023.100469","article-title":"Novel chitosan\/alginate hydrogels as carriers of phenolic-enriched extracts from saffron floral by-products using natural deep eutectic solvents as green extraction media","volume":"6","author":"Cerd\u00e1-Bernad","year":"2023","journal-title":"Curr. Res. Food Sci."},{"key":"10.1016\/j.ejpb.2024.114276_b0315","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s11095-022-03239-5","article-title":"Novel deep eutectic solvent-hydrogel systems for synergistic transdermal delivery of chinese herb medicine and local treatments for rheumatoid arthritis","volume":"39","author":"Xiao","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2024.114276_b0320","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2024.114276_b0325","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12951-022-01567-7","article-title":"Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update","volume":"20","author":"Afarid","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2024.114276_b0330","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1167\/iovs.12-11460","article-title":"Different intravitreal properties of three triamcinolone formulations and their possible impact on retina practice","volume":"54","author":"Chen","year":"2013","journal-title":"Invest. Opthalmol. Visual Sci."},{"key":"10.1016\/j.ejpb.2024.114276_b0335","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.1021\/acssuschemeng.2c07337","article-title":"Role of the deep eutectic solvent reline in the synthesis of gold nanoparticles","volume":"11","author":"Datta","year":"2023","journal-title":"ACS Sustain. Chem. Eng."},{"key":"10.1016\/j.ejpb.2024.114276_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.supflu.2020.104826","article-title":"Design and processing of drug delivery formulations of therapeutic deep eutectic systems for tuberculosis","volume":"161","author":"Roda","year":"2020","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.ejpb.2024.114276_b0345","volume":"421\u2013430","author":"Abdelkader","year":"2012","journal-title":"Controlled and Continuous Release Ocular Drug Delivery Systems : Pros and Cons."},{"key":"10.1016\/j.ejpb.2024.114276_b0350","doi-asserted-by":"crossref","first-page":"39343","DOI":"10.1039\/D1RA06907A","article-title":"Eutectic-based liposome as a potential delivery system of paeonol","volume":"11","author":"Wu","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2024.114276_b0355","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.3390\/ma14247541","article-title":"Development and characterization of nanoemulsions for ophthalmic applications: role of cationic surfactants","volume":"14","author":"Fernandes","year":"2021","journal-title":"Materials"},{"key":"10.1016\/j.ejpb.2024.114276_b0360","doi-asserted-by":"crossref","unstructured":"Krisanti, E. A., Ayuandani, C. B., Salsabila, Z. A. & Mulia, K. Stability of nanoemulsion prepared using betaine-based natural deep eutectic solvent (NADES) and refined coconut oil (RCO) for topical formulation of mangosteen extract. in 060002 (2021). doi:10.1063\/5.0062602.","DOI":"10.1063\/5.0062602"},{"key":"10.1016\/j.ejpb.2024.114276_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116950","article-title":"Physicochemical properties and antibacterial activity of hydrophobic deep eutectic solvent-in-water nanoemulsion","volume":"338","author":"Zeng","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2024.114276_b0370","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13346-017-0359-6","article-title":"Enhanced skin permeation of glabridin using eutectic mixture-based nanoemulsion","volume":"7","author":"Liu","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2024.114276_b0375","unstructured":"Pedro, S. N. et al. Thermo-Responsive Microemulsions Containing Deep Eutectic-Based Antibiotic Formulations for Improved Treatment of Resistant Bacterial Ocular Infections. Advanced Therapeutics n\/a, 2200235."},{"key":"10.1016\/j.ejpb.2024.114276_b0380","doi-asserted-by":"crossref","unstructured":"M.M. Abdallah et al. Potential Ophthalmological Application of Extracts Obtained from Tuna Vitreous Humor Using Lactic Acid-Based Deep Eutectic Systems 2022 Foods (Basel, Switzerland) 11.","DOI":"10.3390\/foods11030342"},{"key":"10.1016\/j.ejpb.2024.114276_b0385","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.1021\/acssuschemeng.8b01687","article-title":"Design of functional therapeutic deep eutectic solvents based on choline chloride and ascorbic acid","volume":"6","author":"Silva","year":"2018","journal-title":"ACS Sustain. Chem. Eng."},{"key":"10.1016\/j.ejpb.2024.114276_b0390","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/jop.2019.0034","article-title":"Ophthalmic drug delivery using iontophoresis: recent clinical applications","volume":"36","author":"Perez","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124001024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124001024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T13:20:38Z","timestamp":1714137638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124001024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":78,"alternative-id":["S0939641124001024"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114276","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can (Natural) deep eutectic systems increase the efficacy of ocular therapeutics?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114276"}}